Qvr LLC Gilead Sciences, Inc. Transaction History

Qvr LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $3,988 - $5,726	64 Added 48.85%	195 $16,000
Q3 2022 Oct 25, 2022	SELL	$59.54 - $68.01 $32,449 - $37,065	-545 Reduced 80.62%	131 $8,000
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $143,203 - $161,289	-2,481 Reduced 78.59%	676 $42,000
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $18,555 - $21,061	-286 Reduced 8.31%	3,157 $229,000
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $215,254 - $232,235	3,180 Added 1209.13%	3,443 $240,000
Q1 2021 May 03, 2021	BUY	$60.0 - $68.46 $15,780 - $18,004	263 New	263 $17,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.